SCHEMBL3636461

SCHEMBL3636461

Oc1ccc(-c2[c]c3ccc(O)cc3cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 15/20 0.50
ESR2 Q92731 14/20 0.50
ABL1 P00519 1/20 0.42
ABCB1 P08183 1/20 0.42
BCR P11274 1/20 0.42
CYP1A2 P05177 2/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
HSD17B1 P14061 1/20 0.41
CYP2B6 P20813 1/20 0.41
CYP2C19 P33261 1/20 0.41
HSD17B2 P37059 1/20 0.41
SHBG P04278 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10594294 0.89 ESR2 (0.52) ESR1ESR2CYP1A2CYP3A4CYP2D6
SCHEMBL9396526 0.88 CYP1A2 (0.44) ESR1ESR2ABL1ABCB1BCR
SCHEMBL8734007 0.84 HSD17B1 (0.55) ESR1ESR2ABL1ABCB1BCR
SCHEMBL9418157 0.81 ESR1 (0.47) ESR1ESR2ABL1ABCB1BCR
SCHEMBL8777379 0.75 CYP1A2 (0.44) ESR1ESR2ABL1ABCB1BCR
SCHEMBL5030675 0.75 CYP1A2 (0.44) ESR1ESR2ABL1ABCB1BCR
SCHEMBL8735778 0.75 ESR2 (0.53) ESR1ESR2CYP1A2CYP3A4CYP2D6
SCHEMBL5591900 0.73 KIF11 (0.50) ESR1ESR2
SCHEMBL27096453 0.72 ESR1 (0.44) ESR1ESR2ABL1ABCB1BCR
SCHEMBL7735652 0.69 HSD17B1 (0.49) CYP1A2CYP3A4CYP2C9HSD17B1HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0346014-B1 Therapeutic product for the treatment of peri- or postmenopausal conditions ZENECA LTD (GB) 1994-08-03 EP claimed
US-5183814-A Administering estrogen and antiestrogen IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1993-02-02 US claimed
EP-0166509-B1 PHENOL DERIVATIVES IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1992-05-13 EP claimed
US-4904661-A ANTIESTROGENS IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1990-02-27 US claimed
EP-0160508-B1 PHENOL DERIVATIVES IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1989-05-31 EP claimed
US-4833135-A Antioestrogenic phenol derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1989-05-23 US claimed
US-4760061-A Antioestrogenic agent IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1988-07-26 US claimed
US-4732912-A ANTIESTROGENS, ANTITUMOR AGENTS IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1988-03-22 US claimed
EP-0124369-B1 PHENOL DERIVATIVES IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1987-06-24 EP claimed
EP-0166509-A1 Phenol derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1986-01-02 EP claimed
EP-0160508-A2 Phenol derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1985-11-06 EP claimed
EP-0124369-A1 Phenol derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1984-11-07 EP claimed
EP-2155769-A2 TISSUE DEGENERATION PROTECTION Katholieke Universiteit Leuven (BE) 2010-02-24 EP disclosed
WO-2008134828-A2 TISSUE DEGENERATION PROTECTION KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2008-11-13 WO disclosed
EP-1140192-B1 USE OF THE CYCLOOXYGENASE-2 INHIBITOR CELECOXIB AND CAPECITABINE FOR COMBINATION THERAPY IN NEOPLASIA SEARLE LLC (US) 2006-04-05 EP disclosed
CN-1164188-A Naphthyl compounds, intermediates, processes, compositions, and methods LILLY CO ELI (US) 1997-11-05 CN disclosed
EP-0124369-B1 PHENOL DERIVATIVES IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1987-06-24 EP disclosed
EP-0166509-A1 Phenol derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1986-01-02 EP disclosed
EP-0160508-A2 Phenol derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1985-11-06 EP disclosed
EP-0124369-A1 Phenol derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1984-11-07 EP disclosed